Envoy Medical, Inc. (COCH) - רווח נקי למניה (EPS TTM)

Envoy Medical, Inc. (COCH) is currently penetrating the hearing implant niche, where sales growth depends on surgeon training. Insurance coverage and low demand cyclicality provide business stability. The company's technological breakthrough is a fully implantable device without external components. Net income per share over the last 12 months on GURU.Markets demonstrates current dynamics, and -4.68 captures the current state of the parameter.
COCH (Envoy Medical, Inc): פילוחים אנליטיים ודוחות לפי אינדיקטורים

Earnings per share (EPS) reflects the portion of profit allocated to each ordinary share per year. By analyzing the trend of the rolling annual EPS, an investor assesses the efficiency of capital allocation. This metric measures a business's ability to generate income after deducting all expenses. For Envoy Medical, Inc. (COCH), this figure is volatile due to implant implementation costs. EPS growth would confirm successful insurance coverage for the products.